SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Triple Analysis: Breast Cancer, Melanoma and Peptides - 2013 Report

[December 03, 2013]

Research and Markets: Triple Analysis: Breast Cancer, Melanoma and Peptides - 2013 Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/bjhswd/triple_analysis) has announced the addition of the "Triple Analysis: Breast Cancer, Melanoma and Peptides" report to their offering.

This report focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.

Synopsis (News - Alert)

Part I: Breast Cancer

based on the publicatin: 'Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others'


The breast cancer drug report part comprises defined and up to date development strategies for 470 drugs within the portfolio of 247 companies world-wide, from Ceased to Marketed. The report extensively analyses their 234 identified drug targets, organized into 223 drug target strategies, and assesses them in breast cancer drug development.

Part II: Melanoma

based on the publication: 'Melanoma Drug Development Analysis: From First-in-Class to Best-in-Class?'

The melanoma drug report part comprises defined and up to date development strategies for 282 drugs within the portfolio of 164 companies world-wide, from Ceased to Marketed. The report extensively analyses their 226 identified drug targets, organized into 187 drug target strategies, and assesses them in melanoma.

Part III: Peptides

based on the publication: 'Cancer Peptides: From First-in-Class to Best-in-Class?'

The peptide drug report part comprises defined and up to date development strategies for 171 drugs in oncology within the portfolio of 114 companies world-wide, from Ceased to Marketed. The report extensively analyses their 132 identified drug targets, organized into 109 drug target strategies, and assesses them in 62 cancer indications.

For more information visit http://www.researchandmarkets.com/research/bjhswd/triple_analysis

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.